Ethicon Announces FDA Approval For SURGICEL Powder Absorbable Hemostat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Johnson & Johnson (NYSE: JNJ) | Delayed: 263.81 -3.8 (1.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $267.61 | 52 Week High | $126.07 | |||
| Open | $265.82 | 52 Week Low | $94.28 | |||
| Day High | $266.03 | P/E | 54.85 | |||
| Day Low | $262.40 | EPS | $4.81 | |||
| Volume | 5,309,109 | |||||
